Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Pancreatic Neoplasms × Decitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 2 Pancreatic Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Colonic Neoplasms 1

Interventions

Gemcitabine 17 Standard of Care 13 Radiosurgery 13 Drug Therapy 13 Blood Specimen Collection 11 Endoscopic Ultrasound-Guided Fine Needle Aspiration 9 Pancreaticoduodenectomy 8 Magnetic Resonance Spectroscopy 8 Practice Guidelines as Topic 7 Methods 7 Exercise 7 Biopsy, Fine-Needle 7 Early Intervention, Educational 6 Capecitabine 6 Resistance Training 5 Radiofrequency Ablation 5 Psychiatric Rehabilitation 5 Oxaliplatin 5 Fluorouracil 5 Cholangiopancreatography, Endoscopic Retrograde 5 130-nm albumin-bound paclitaxel 5 Stents 4 Specimen Handling 4 Secretin 4 Irinotecan 4 Heavy Ion Radiotherapy 4 Electroporation 4 Biopsy 4 Surveys and Questionnaires 3 Sodium Chloride 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02685228 2016-02-18

SLOWDOSE001

The First Hospital of Jilin University

Phase NA Unknown

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡